Tonix is developing innovative pharmaceutical products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD, and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, to be developed as a potential smallpox-preventing vaccine.

Pharmaceutical

Tonix Pharmaceuticals

Tonix Pharmaceuticals' headquarters in New York, NY, United States

Seth Lederman

Ram Patalapati

Jean Engels

Sina Bavari

Bradley Saenger

Jessica Edgar Morris

Gregory Sullivan

Siobhan Fogarty

Adeoye Olukotun

Margaret Smith Bell

David Grange

James Treco

Carolyn E. Taylor

Richard H. Bagger

R. Newcomb Stillwell

Description

People (9)

Seth Lederman

Gregory Sullivan

Richard H. Bagger

Zeil Rosenberg

Candace Flint

Megha Shah Tevar

Lisa M.

Ram Patalapati

Thomas Englese

Jobs